Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.

Neuromolecular medicine - 1 Mar 2013

Teixeira Antonio L, Diniz Breno S, Campos Alline C, Miranda Aline S, Rocha Natalia P, Talib Leda L, Gattaz Wagner F, Forlenza Orestes V

Abstract excerpt

Adiponectin, an adipocytokine released by the adipose tissue and has important roles in the metabolic regulation and inflammatory control, may play an important roles in the physiopathology of psychiatric and neurodegenerative disorders. The aim of the present work was to evaluate adiponectin serum levels in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) as compared to cognitively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiponectin
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Body Mass Index

Share to Brazil

Share to Cardiovascular Diseases

Share to Cognitive Dysfunction

Share to Dyslipidemias

Share to Educational Status

Source

Identifiers

PMID: 23055000
DOI: 10.1007/s12017-012-8201-2

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.PMID 23055000Read ↗

Assessing adipokines as potential biomarkers of dementia, Alzheimer’s disease, and mild cognitive impairment: a systematic review and meta-analysisSemantic proximity Read ↗

Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairmentSemantic proximity Read ↗

Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment.Semantic proximity Read ↗

Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.Semantic proximity Read ↗

Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han.Semantic proximity Read ↗

Persistent mild cognitive impairment in geriatric depression.Semantic proximity Read ↗

Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers.Semantic proximity Read ↗

Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer’s DiseaseSemantic proximity Read ↗

Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study.Semantic proximity Read ↗

Subclinical atherosclerosis and subsequent cognitive function.Semantic proximity Read ↗

The obesity paradox in cognitive decline: Impact of BMI dynamics and APOE genotypes across various cognitive status.Semantic proximity Read ↗

Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.